James Stone to Antineoplastic Agents
This is a "connection" page, showing publications James Stone has written about Antineoplastic Agents.
Connection Strength
0.053
-
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma. Cancer Discov. 2017 03; 7(3):252-263.
Score: 0.053